Literature DB >> 23599188

Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.

Ashley Minuk, Michel J Belliveau, David R P Almeida, Stephen J Dorrepaal, Jeffrey S Gale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23599188     DOI： 10.1001/jamaophthalmol.2013.2465

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  10 in total

Review 1.  The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.

Authors:  Gregory Heath; Archana Airody; Richard Peter Gale
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 2.  Fingolimod: therapeutic mechanisms and ocular adverse effects.

Authors:  P Mandal; A Gupta; W Fusi-Rubiano; P A Keane; Y Yang
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

Review 3.  Cardiovascular effects of fingolimod: A review article.

Authors:  Mohaddeseh Behjati; Masoud Etemadifar; Morteza Abdar Esfahani
Journal:  Iran J Neurol       Date:  2014-07-04

4.  Continuing fingolimod after development of macular edema: A case report.

Authors:  Vivien Li; Jack Kane; Helen H L Chan; Anthony J Hall; Helmut Butzkueven
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-05-15

5.  Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?

Authors:  Refik Pul; Alma Osmanovic; Holger Schmalstieg; Amelie Pielen; Kaweh Pars; Philipp Schwenkenbecher; Kurt Wolfram Sühs; Özlem Yildiz; Benedikt Frank; Martin Stangel; Thomas Skripuletz
Journal:  Int J Mol Sci       Date:  2016-12-14       Impact factor: 5.923

Review 6.  Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.

Authors:  Horace Massa; Spyros Y Pipis; Georgios D Panos; Temilade Adewoyin; Athanasios Vergados; Sudeshna Patra
Journal:  Clin Ophthalmol       Date:  2019-09-10

Review 7.  Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature.

Authors:  Juliana Muñoz-Ortiz; Juliana Reyes-Guanes; Estefanía Zapata-Bravo; Laura Mora-Muñoz; Juan Antonio Reyes-Hurtado; Luis Octavio Tierradentro-García; William Rojas-Carabali; Marcela Gómez-Suarez; Alejandra de-la-Torre
Journal:  Syst Rev       Date:  2021-10-28

8.  Diagnosis and Management of Fingolimod-Associated Macular Edema.

Authors:  Chunjiang Wang; Zhenzhen Deng; Liying Song; Wei Sun; Shaoli Zhao
Journal:  Front Neurol       Date:  2022-07-15       Impact factor: 4.086

Review 9.  Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknown.

Authors:  Heather E Moss
Journal:  Eye Brain       Date:  2017-06-29

10.  Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications.

Authors:  Rachel Husmann; John B Davies; Malik Ghannam; Brent Berry; Praful Kelkar
Journal:  Clin Mol Allergy       Date:  2020-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.